Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia
Psychopharmacology, May 2006
—
Nighttime agitation occurs frequently in patients with dementia and represents the number one burden on caregivers today. Current treatment options are few and limited due to substantial side effects. The aim of the study was to measure the effect of the cannabinoid dronabinol…